Navigation Links
Amgen Announces 2013 Third Quarter Dividend
Date:7/26/2013

THOUSAND OAKS, Calif., July 26, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced that its Board of Directors today declared a $0.47 per share dividend for the third quarter of 2013. The dividend will be paid on Sept. 6, 2013, to all stockholders of record as of the close of business on Aug. 16, 2013. 

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping people around the world in the fight against serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.

Forward-Looking Statements
This news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in our Form 10-K for the year ended Dec. 31, 2012, and in any subsequent periodic reports on Form 10-Q and Form 8-K.  Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. The Company's results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and r
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy
2. Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim)
3. Amgen Announces 2012 First Quarter Dividend
4. Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012
5. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
6. Amgen Announces Webcast of 2011 Fourth Quarter and Full Year Financial Results
7. Amgen to Acquire Micromet
8. Amgen to Present at the Leerink Swann Global Healthcare Conference
9. Amgen Announces 2012 Third Quarter Dividend
10. Amgen Names Ray Jordan Senior Vice President, Corporate Affairs
11. Amgen To Present At The 24th Annual Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Shire plc (LSE: SHP, ... biopharmaceutical company, and ArmaGen, a US privately held ... collaboration agreement for AGT-182, an investigational enzyme replacement ... the central nervous system (CNS) and somatic manifestations ... collaboration strengthens Shire,s rare disease pipeline of innovative ...
(Date:7/23/2014)... With the ability to record continuously at over 500 ... minutes, Fastec Imaging has brought the same ease-of-use of today’s ... a high speed camera that can be used as simply ... proclaims Matt Kearney, VP of Sales for Fastec Imaging. ... simplify the traditionally complicated workflow of a high speed camera. ...
(Date:7/23/2014)... Astra Nova Training , a ... pharma training services, and the Alliance for ... non-profit integrating the expertise and investments of research ... system for clinical trials, are pleased to announce ... of industry professionals through improved and easily available ...
(Date:7/22/2014)... and Technology (NIST) and California Institute of Technology ... atomic clock that is based on a chip-scale ... clock, featured on the cover of the inaugural ... is the first demonstration of all-optical control of ... frequencies to lower microwave frequencies. (Optical frequencies are ...
Breaking Biology Technology:Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 2Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 3Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 4Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 5Fastec Imaging Introduces the First High Speed Camcorder 2Fastec Imaging Introduces the First High Speed Camcorder 3Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 2Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 3'Comb on a chip' powers new NIST/Caltech atomic clock design 2
... Highlights: - Revenues of $88.4 million, up 14% from the, prior ... 47% over last year,s third quarter - Operating cash flow of ... year 2008 ... earnings guidance, COLUMBIA, Md., Sept. 4 Martek Biosciences,Corporation (Nasdaq: ...
... The University of North Carolina-Chapel Hill ... Safety Sciences, RESEARCH TRIANGLE PARK, N.C., Sept. 4 ... of North Carolina at,Chapel Hill announced they are establishing ... led by Dr. Paul Watkins, one of the world,s ...
... -- Genesis,Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ... the People,s Republic,of China, today announced that it ... stock which will begin trading under the symbol ... stock will no longer trade,under the symbol "GTEC" ...
Cached Biology Technology:Martek Announces Third Quarter 2008 Financial Results 2Martek Announces Third Quarter 2008 Financial Results 3Martek Announces Third Quarter 2008 Financial Results 4Martek Announces Third Quarter 2008 Financial Results 5Martek Announces Third Quarter 2008 Financial Results 6Martek Announces Third Quarter 2008 Financial Results 7Martek Announces Third Quarter 2008 Financial Results 8Martek Announces Third Quarter 2008 Financial Results 9Martek Announces Third Quarter 2008 Financial Results 10New Hamner-UNC Center for Drug Safety Sciences 2New Hamner-UNC Center for Drug Safety Sciences 3Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol 2Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol 3
(Date:7/23/2014)... State University shows that urban "heat islands" are slowly ... factor is that researchers have found warmer temperatures increase ... insect a significant tree pest by 300 ... adult gloomy scales on urban trees. , "We,d been ... scale in cities, and now we know why," says ...
(Date:7/23/2014)... of Antarctic fur seals, alongside decades of in-depth ... of climate change on a population of top-predators. ... findings show that the seals have significantly altered ... are associated with climate conditions. Despite a shift ... is not passing down through generations, leaving the ...
(Date:7/23/2014)... Popeye super strength, but it also holds the promise ... the ability to convert sunlight into a clean, efficient ... an international group using spinach to study the proteins ... the sun,s energy into carbohydrates used to power cellular ... the most efficient system ever built, capable of converting ...
Breaking Biology News(10 mins):Urban heat boosts some pest populations 200-fold, killing red maples 2Urban heat boosts some pest populations 200-fold, killing red maples 3Genetic study shows major impact of climate change on Antarctic fur seals 2Genetic study shows major impact of climate change on Antarctic fur seals 3Spinach could lead to alternative energy more powerful than Popeye 2
... up with a new twist on the mysterious visual ... The scientists have found that monkeys sense it too. ... Japanese researcher nearly three decades ago, describes that disquieting ... to be as human-like as possible -- whether computer ...
... are setting their minimum population size targets too low ... by University of Adelaide and Macquarie University scientists which ... to persist in the face of global climate change ... individuals or more. The findings have been published online ...
... multi-national research team has discovered that two genetic factors converge ... investigators from the United States, Italy and South Africa ... in the gene NOS1AP increase the risk of cardiac symptoms ... disease called congenital long-QT syndrome. , The findings will help ...
Cached Biology News:Like humans, monkeys fall into the 'uncanny valley' 2Like humans, monkeys fall into the 'uncanny valley' 3Conservation targets too small to stop extinction 2Gene mingling increases sudden death risk 2Gene mingling increases sudden death risk 3
Reacti-Bind DNA Coating Solution...
... regulate cell stretching or compression of a ... Computer controlled so you can precisely regulate ... to produce 64 unique strain parameters. ST-160 ... ST-150. Both models are compatible with Nikon, ...
... EasyCount ViaSure Kit is used in conjunction with ... nucleated cells automatically. The ViaSure Staining Reagent ... - Acridine Orange and Ethidium Bromide to identify ... test, while the EasyCount Slide 6 Multi-well ...
... Basic power supply are used for electrophoretic blotting ... accommodates two 7.5 x 10 cm gels and ... Bio-Ice cooling unit, buffer tank, lid with power ... power supply, 100-120 and 220-240 V, provides output ...
Biology Products: